Systemic chemotherapy for the treatment
β
Yan Li; Edward F McClay
π
Article
π
2002
π
Elsevier Science
π
English
β 118 KB
The role of systemic chemotherapy in the treatment of patients with metastatic melanoma remains of questionable benefit. Despite encouraging phase II data from multiple institutions that suggested an improved overall response rate for patients treated with the Dartmouth regimen, recently completed p